2010
DOI: 10.1186/1758-2652-13-s4-o21
|View full text |Cite
|
Sign up to set email alerts
|

Virological outcomes in ARV‐naïve patients switching or not from a first successful boosted PI‐regimen to efavirenz, nevirapine or abacavir regimens

Abstract: 7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles